MiR-124 Reduced Neuroinflammation after Traumatic Brain Injury by Inhibiting TRAF6

Yongxiang Yang1,2, Yuqin Ye2,3, Kexia Fan1

  • 1Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, China.

Neuroimmunomodulation
|March 1, 2023
PubMed
Abstract

Insights

Upregulating miR-124 in traumatic brain injury (TBI) promotes beneficial M2 microglia polarization and reduces neuroinflammation by inhibiting TRAF6, improving neurological deficits.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Neuroinflammation, primarily mediated by microglia, exacerbates secondary injury following traumatic brain injury (TBI).
  • MicroRNA-124 (miR-124) is implicated in microglial polarization via the Toll-like receptor 4 (TLR4) signaling pathway, but its precise role in TBI-induced neuroinflammation remains unclear.

Purpose of the Study:

  • To elucidate the role and underlying mechanism of miR-124 in TBI-induced neuroinflammation mediated by microglia.
  • To investigate the therapeutic potential of modulating miR-124 expression in TBI.

Main Methods:

  • Quantitative real-time PCR (RT-PCR) to measure miR-124 expression post-TBI.
  • Administration of miR-124 mimics or inhibitors to modulate miR-124 levels in vivo.
  • Assessment of microglial polarization markers, inflammatory cytokines (ELISA), and TLR4 signaling pathway components (Western blot).
  • Evaluation of neurological deficits using the neurological severity score (NSS) and Morris water maze (MWM) tests.
  • In vitro experiments to identify miR-124's direct target in the TLR4 pathway.

Main Results:

  • miR-124 expression was significantly downregulated in the injured brain after TBI.
  • Upregulation of miR-124 promoted M2 microglial polarization and suppressed the TLR4 signaling pathway.
  • miR-124 inhibition of TRAF6 was identified as a key mechanism for reducing neuroinflammation.
  • Enhanced miR-124 levels led to reduced neuroinflammation and improved neurological function in TBI models.

Conclusions:

  • Upregulation of miR-124 mitigates TBI-induced neuroinflammation and neurological deficits.
  • The mechanism involves promoting M2 microglial polarization and inhibiting the TRAF6 protein within the TLR4 signaling pathway.